Correlation Between Eterna Therapeutics and NRX Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and NRX Pharmaceuticals, you can compare the effects of market volatilities on Eterna Therapeutics and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and NRX Pharmaceuticals.

Diversification Opportunities for Eterna Therapeutics and NRX Pharmaceuticals

0.21

Correlation Coefficient

Eterna Therapeutics  NRX Pharmaceuticals

Modest diversification

The 3 months correlation between Eterna and NRX is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and NRX Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and NRX Pharmaceuticals

Given the investment horizon of 90 days Eterna Therapeutics is expected to generate 9.64 times less return on investment than NRX Pharmaceuticals. But when comparing it to its historical volatility, Eterna Therapeutics is 1.09 times less risky than NRX Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. NRX Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  135.00  in NRX Pharmaceuticals on December 2, 2024 and sell it today you would earn a total of  92.00  from holding NRX Pharmaceuticals or generate 68.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Eterna Therapeutics  vs.  NRX Pharmaceuticals

Eterna Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eterna Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Eterna Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

NRX Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NRX Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, NRX Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eterna Therapeutics and NRX Pharmaceuticals

The main advantage of trading using opposite Eterna Therapeutics and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.

The idea behind Eterna Therapeutics and NRX Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.